Cancer Genetics

$2.50
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.09 (+3.83%) Today
+$0.06 (+2.46%) As of 5:00 PM EST after-hours

Why Robinhood?

You can buy or sell CGIX and other stocks, options, and ETFs commission-free!

About CGIX

Cancer Genetics, Inc. engages in the development, commercialization, and sale of molecular and biomarker-based tests and services. Through its Select One Clinical Trials program, the firm provides a range of clinical trial services for both oncology and non-oncology genetic testing such as bioinformatics, biomarker solutions, bio repository solutions, consulting, cytogenetic testing, nucleic acid extraction and purification, flow cytometry, Focus: NGS Panel, gene expression analyses, genotyping, and pharmacogenomics. The company was founded by Raju S. K. Chaganti on April 8, 1999 and is headquartered in Rutherford, NJ. The listed name for CGIX is Cancer Genetics, Inc. Common Stock.

CEO
John A. Roberts
Employees
110
Headquarters
Rutherford, New Jersey
Founded
1999
Market Cap
9.94M
Price-Earnings Ratio
Dividend Yield
Average Volume
127.97K
High Today
$2.48
Low Today
$2.34
Open Price
$2.40
Volume
274.90K
52 Week High
$10.39
52 Week Low
$1.92

Collections

CGIX Earnings

-$0.90
-$0.60
-$0.30
-$0.00
Q4 FY18
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Estimated
per share
Actual
-$0.58 per share

You May Also Like